Sickle Cell Anemia, May: “Crucial knowledge of the disease to avoid organ damage”
"In sickle cell anemia, the presence of pain can indicate damage to the liver, heart, or in any case a ...
"In sickle cell anemia, the presence of pain can indicate damage to the liver, heart, or in any case a ...
"Crizanlizumab is a very innovative drug because it could help us doctors manage even those patients who have failed or ...
From today in Italy there is a reimbursable therapy for the prevention of vaso-occlusive crises, serious and unpredictable phenomena that ...
"Thanks to this new drug and working in synergy with experts, hospitals and patient associations, we must and can change ...
from Vera Martinella Patients from an early age can suffer from painful, unpredictable and dangerous vaso-occlusive crises. Now there is ...
“Sickle cell anemia is a congenital and very important disease, regardless of its incidence, with an enormous impact on the ...
Novartis announced today that the Italian Medicines Agency has approved the reimbursement Adakveo * (crizanlizumab) for the prevention of vaso-occlusive ...